PLoS ONE 2009-01-01

The germinal center kinase GCK-1 is a negative regulator of MAP kinase activation and apoptosis in the C. elegans germline.

Katherine R Schouest, Yasuhiro Kurasawa, Tokiko Furuta, Naoki Hisamoto, Kunihiro Matsumoto, Jill M Schumacher

Index: PLoS ONE 4 , e7450, (2009)

Full Text: HTML

Abstract

The germinal center kinases (GCK) constitute a large, highly conserved family of proteins that has been implicated in a wide variety of cellular processes including cell growth and proliferation, polarity, migration, and stress responses. Although diverse, these functions have been attributed to an evolutionarily conserved role for GCKs in the activation of ERK, JNK, and p38 MAP kinase pathways. In addition, multiple GCKs from different species promote apoptotic cell death. In contrast to these paradigms, we found that a C. elegans GCK, GCK-1, functions to inhibit MAP kinase activation and apoptosis in the C. elegans germline. In the absence of GCK-1, a specific MAP kinase isoform is ectopically activated and oocytes undergo abnormal development. Moreover, GCK-1- deficient animals display a significant increase in germ cell death. Our results suggest that individual germinal center kinases act in mechanistically distinct ways and that these functions are likely to depend on organ- and developmental-specific contexts.


Related Compounds

  • NS 3763

Related Articles:

Adenine nucleotide translocator cooperates with core cell death machinery to promote apoptosis in Caenorhabditis elegans.

2009-07-01

[Mol. Cell. Biol. 29 , 3881-93, (2009)]

Neurotoxic effects of TDP-43 overexpression in C. elegans.

2010-08-15

[Hum. Mol. Genet. 19 , 3206-18, (2010)]

Shared developmental roles and transcriptional control of autophagy and apoptosis in Caenorhabditis elegans.

2011-05-01

[J. Cell Biol. 124 , 1510-8, (2011)]

MSP and GLP-1/Notch signaling coordinately regulate actomyosin-dependent cytoplasmic streaming and oocyte growth in C. elegans.

2009-07-01

[Development 136 , 2223-34, (2009)]

In vitro characterization of 5-carboxyl-2,4-di-benzamidobenzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors.

2004-06-01

[J. Pharmacol. Exp. Ther. 309 , 1003-1010, (2004)]

More Articles...